Suraksha Diagnostic Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Ritu Mittal
Chief executive officer
₹18.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 18.1yrs |
| CEO ownership | 15.9% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | ₹18m | n/a | ₹236m |
| Mar 31 2023 | ₹14m | n/a | ₹65m |
| Mar 31 2022 | ₹14m | n/a | ₹208m |
| Mar 31 2021 | ₹9m | ₹9m | ₹64m |
Compensation vs Market: Ritu's total compensation ($USD211.64K) is about average for companies of similar size in the Indian market ($USD174.18K).
Compensation vs Earnings: Ritu's compensation has increased by more than 20% in the past year.
CEO
Ritu Mittal (51 yo)
18.1yrs
Tenure
₹18,000,000
Compensation
Ms. Ritu Mittal is Joint Managing Director, Chief Executive Officer & Director of Suraksha Diagnostic Private Limited. Ms. Mittal also has an experience in the field of medical and diagnostics business. Sh...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Joint MD | 18.1yrs | ₹18.00m | 15.89% ₹ 3.4b | |
| Non-Executive Non Independent Director | less than a year | no data | 10.84% ₹ 2.3b | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Non-Executive Non Independent Director | 1.1yrs | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Chairman & Joint MD | 19.8yrs | ₹18.00m | 4.99% ₹ 1.1b | |
| Independent Director | less than a year | no data | no data |
0.4yrs
Average Tenure
64.5yo
Average Age
Experienced Board: SURAKSHA's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 11:19 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Suraksha Diagnostic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|